Royalty Pharma (RPRX) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn | 208.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 556.90 Mn |
| Mar 31, 2026 | 556.84 Mn |
| Dec 31, 2025 | 564.46 Mn |
| Sep 30, 2025 | 559.61 Mn |
| Jun 30, 2025 | 562.30 Mn |
| Mar 31, 2025 | 578.10 Mn |
| Dec 31, 2024 | 594.11 Mn |
| Sep 30, 2024 | 592.73 Mn |
| Jun 30, 2024 | 596.91 Mn |
| Mar 31, 2024 | 597.48 Mn |
| Dec 31, 2023 | 602.90 Mn |
| Sep 30, 2023 | 601.14 Mn |
| Jun 30, 2023 | 605.86 Mn |
| Mar 31, 2023 | 607.25 Mn |
| Dec 31, 2022 | 437.97 Mn |
| Sep 30, 2022 | 607.23 Mn |
| Jun 30, 2022 | 607.21 Mn |
| Mar 31, 2022 | 607.20 Mn |
| Dec 31, 2021 | 414.80 Mn |
| Sep 30, 2021 | 607.17 Mn |